October 8, 2013
Astellas Pharma and US biotech venture Mitokyne have agreed on an exclusive research and development collaboration in mitochondrial-related disease therapies, Astellas said on October 7. The two companies aim to discover and develop novel drugs for the treatment of mitochondrial-related...read more